Thompson Davis & Co’s GeoVax Labs GOVX Stock Holding History

Thompson Davis & Co’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-27	Closed	-$8K	–	98
2022 Q2	$8K	Buy	+27	New	+$11.9K	0.01%	95

Other funds holding GOVX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HLAM

Hidden Lake Asset Management New York $331M AUM 122.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Thompson Davis & Co's GOVX Position: Q3 2022 in Review

Thompson Davis & Co sold out of GeoVax Labs (GOVX) in Q3 2022, closing a stake of 27 shares — an estimated $8K sold.

Thompson Davis & Co first reported a position in GOVX in Q2 2022 and held it in 1 quarter. The position peaked at $8K in Q2 2022. 21 funds tracked by Wall St. Rank hold GOVX as of Q3 2022.

Thompson Davis & Co reported no remaining GeoVax Labs position as of Q3 2022 after selling out during the quarter.
Thompson Davis & Co sold 27 GeoVax Labs shares in Q3 2022, an estimated $8K.
Thompson Davis & Co first reported a position in GeoVax Labs in Q2 2022 and held it in 1 quarter.
Thompson Davis & Co's GeoVax Labs position peaked at $8K in Q2 2022.
21 funds tracked by Wall St. Rank held GeoVax Labs as of Q3 2022.

Based on Thompson Davis & Co's 13F filing for Q3 2022, filed 9 Nov 2022.